UFC middleweight Abu Azaitar has received a seven-month suspension from USADA for multiple anti-doping violations.
Azaitar tested positive for tamoxifen, a selective estrogren receptor module, in urine samples collected on Aug. 25, Sept. 4, Sept. 9 and Sept. 17, the organization announced Monday. Tamoxifen is often linked to post-cycle steroid use in athletes.
Azaitar provided medical records that he was prescribed tamoxifen by a doctor to treat “symptoms” for an undisclosed condition. However, the fighter “lacked a valid therapeutic use exemption (TUE) and his subsequent application for a retroactive TUE was denied due to lack of sufficient medical justification.